Ziprasidone Pharmacology

On this episode of the Real Life Pharmacology Podcast, I cover ziprasidone pharmacology.

Ziprasidone has dopamine blocking activity and is classified as a second generation antipsychotic.

Ziprasidone tends to have lower metabolic syndrome risks compared to other antipsychotics like clozapine and olanzapine.

QTc prolongation is a significant risk with ziprasidone and be aware of drug interactions and electrolyte imbalances that may increase this risk.

I discuss important drug interactions on the podcast, be sure to check out my latest project which is a 200+ page book on managing drug interactions in primary care.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Leave a Reply

Your email address will not be published. Required fields are marked *